Drug Discovery Leaders Warn U.S. Cuts Endanger AI Edge
As Washington trims billions from health funding, AI drug discovery leaders warn the timing could widen the gap with ...
Understanding when points offer greater value than cash back can enhance your credit card strategy. Discover these key moments.
28,161 articlesAs Washington trims billions from health funding, AI drug discovery leaders warn the timing could widen the gap with ...
AI is becoming a central force in personal finance, from investing apps to retirement planning. This report breaks do...
When a metropolitan bank director sells shares, it catches the eye of investors. This article explains insider filing...
Insider moves can reveal how company insiders view the path ahead. This guide breaks down what it means when a chief ...
A biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
Tesla stock has slid about 18% from its December peak as deliveries declined and autonomy safety metrics raise questi...
A surge of fear, uncertainty, and doubt sweeps social feeds as Ethereum faces ETF-driven volatility. This report brea...
Gen X is turning to facelifts as GLP-1 weight-loss drugs reshape faces, pushing middle-aged adults to consider surgic...
Micron Technology posted strong results, yet the stock slipped. This guide weighs whether micron's dip: great chance ...
PennantPark pays an about 20% yield through an $0.08 monthly payout, but a spillover reserve backs part of the divide...
Remax Holdings posted a revenue decline and a sharper net loss in Q1 2026, while debt rose to $436 million. Real Brok...
A growing number of newlyweds confront the mine-vs.-ours debt question as one partner considers wiping out the $28,00...